NCT04503408View on ClinicalTrials.gov

A Comparison of Clinical Parameters in With and Without Abnormal Glucose Tolerance.

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 13, 2019

Primary Completion Date

March 11, 2020

Study Completion Date

March 11, 2020

Conditions
Cystic Fibrosis-related DiabetesDiabetes MellitusCystic Fibrosis
Trial Locations (1)

06230

Elif Kocaaga, Ankara

All Listed Sponsors
lead

Hacettepe University

OTHER

NCT04503408 - A Comparison of Clinical Parameters in With and Without Abnormal Glucose Tolerance. | Biotech Hunter | Biotech Hunter